about
Sphingolipid degradation by Leishmania major is required for its resistance to acidic pH in the mammalian host.In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune responseCD8(+) T cells in leishmania infections: friends or foes?Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis.Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of vaccines against leishmaniasis.
@en
Development of vaccines against leishmaniasis.
@nl
type
label
Development of vaccines against leishmaniasis.
@en
Development of vaccines against leishmaniasis.
@nl
prefLabel
Development of vaccines against leishmaniasis.
@en
Development of vaccines against leishmaniasis.
@nl
P1476
Development of vaccines against leishmaniasis
@en
P2093
Modabber F
P577
1990-01-01T00:00:00Z